PAYER POLICY CHANGES

J0752 Insurance Policy Changes

HCPCS J0752 is officially defined as "Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)." HCPCS J0752 is referenced in 15 tracked payer policy changes from Blue Cross Blue Shield of Vermont, Medicare/CMS - Transmittals, and 8 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J0752 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch J0752

Get one email when a payer policy names J0752, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for J0752

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for J0752 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.